AuthorisedTherapeutic exploratory (Phase II)Interventional

Mesotherapy treatment of irritable bowel syndrome

Researchers are conducting a study to explore mesotherapy as a potential treatment for irritable bowel syndrome (IBS). IBS is a common and often uncomfortable condition that affects the digestive system. This study is in an early stage, often called a Phase II trial, which means the main goal is to see if mesotherapy shows promise and is safe enough to investigate further. They want to understand if this treatment might help reduce common IBS symptoms. The research is open to adults aged 18 and above, regardless of gender. If you have IBS and are interested in learning more, this study could be an opportunity to contribute to understanding new treatment options.

At a glance

Status

Authorised

Phase

Therapeutic exploratory (Phase II)

Sponsor

Polyclinique De L'europe

Enrolment target

Start

08 Feb 2024

Irritable bowel syndrome

What is this study about?

This research is looking into a treatment called mesotherapy for people who have irritable bowel syndrome, or IBS. IBS is a common condition that can cause tummy pain, bloating, and changes in how often you go to the toilet, like diarrhoea or constipation. It can be quite uncomfortable and affect daily life for many people.

Mesotherapy is a technique where small amounts of medication are injected just under the skin. In this study, researchers want to see if applying this technique could help to ease the symptoms of IBS. This is an early-stage study, often called a 'Phase II' trial. This means that instead of proving a treatment works for everyone, the main goal is to find out if it is safe, and if there are any signs that it could be effective for IBS symptoms in some people.

The findings from this study will help decide if mesotherapy should be studied further in larger trials. This kind of research is really important because it helps scientists learn more about new ways to manage conditions like IBS, potentially offering more options for people in the future.

Key takeaways

The study is investigating mesotherapy for Irritable Bowel Syndrome (IBS).
It's an early-stage study (Phase II) to check safety and potential benefits.
Adults aged 18 and over, of any gender, with IBS can be considered.
Participation involves receiving injections and having your symptoms monitored.
There's a chance of improving symptoms, but also potential side effects.
You can stop participating at any time you wish.

Who may be eligible?

This study is particularly looking for adults who have been diagnosed with irritable bowel syndrome (IBS). To be considered, you need to be at least 18 years old – there's no upper age limit, meaning older adults are also welcome to take part.

Both men and women are invited to participate in this study. The researchers want to include a wide range of people to get a better understanding of how the treatment might work across different individuals with IBS.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Do you have a diagnosis of Irritable Bowel Syndrome (IBS)?
Are you male or female?
Are you able to attend clinic appointments for the study?

Answer every question to see your result.

What does participation involve?

The specific details of what taking part involves aren't fully described, but typically in an early-stage study like this, you would have several visits to a clinic or hospital. These visits would likely include health checks and assessments of your IBS symptoms to see how you're feeling before, during, and after the treatment process.

If you join, you would receive the mesotherapy treatment, which involves small injections. You might also be asked to keep a diary of your symptoms. There would be follow-up appointments to monitor your progress and make sure you're doing well. The total duration of your involvement in the study would be explained to you before you agree to take part.

Potential risks and benefits

Taking part in a study like this might offer a potential benefit of receiving a new treatment that could improve your IBS symptoms, although this is not guaranteed as it's an investigational treatment. However, all medical treatments carry some potential risks. With mesotherapy, possible side effects could include discomfort, redness, or bruising at the injection sites. The research team will carefully explain all known and potential risks to you. Remember, deciding whether to take part is entirely your choice, and you are free to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

—
Unverified
France

Common questions

What is mesotherapy?

Mesotherapy is a technique where very small amounts of medicine are injected just under the surface of the skin.

What is Irritable Bowel Syndrome (IBS)?

IBS is a common stomach and gut problem that can cause tummy pain, bloating, and changes in bowel habits like diarrhoea or constipation.

Is this a new treatment?

This study is exploring mesotherapy as a new approach for IBS, but mesotherapy itself has been used for other conditions.

Who can join this study?

Adults aged 18 and over, both men and women, who have IBS may be eligible to take part.

What does 'Phase II' mean?

Phase II means it's an early-stage study primarily looking at the safety of the treatment and if there are any signs that it might work for the condition.